Literature DB >> 33595253

Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.

.   

Abstract

ABSTRACT: An estimated 150,000 youth and 1.4 million adults living in the United States identify as transgender. This Committee Opinion offers guidance on providing inclusive and affirming care as well as clinical information on hormone therapy and preventive care; it also cites existing resources for those seeking information on the care of transgender adolescents. The social and economic marginalization of transgender individuals is widespread, which leads to health care inequities and poorer health outcomes for this population. To reduce the inequities experienced by the transgender community, the provision of inclusive health care is essential. Obstetrician-gynecologists should strive to make their offices open to and inclusive for all individuals and should seek out education to address health care disparities, both in their individual practices and in the larger health care system. In order to provide the best care for patients, it is useful to know which health care professionals to include in a referral network for primary care and to have many clinician and surgeon options given the many different therapies available and the different sites at which these therapies are offered. It is important to remember that although hormone therapy is a medically necessary treatment for many transgender individuals with gender dysphoria, not all transgender patients experience gender dysphoria and not everyone desires hormone treatment. Gender-affirming hormone therapy is not effective contraception. Sexually active individuals with retained gonads who do not wish to become pregnant or cause pregnancy in others should be counseled about the possibility of pregnancy if they are having sexual activity that involves sperm and oocytes. Although being knowledgeable about the medications used for gender transition and potential risks and side effects is important, specific certification for prescribing them is not required and should not be a limiting factor in helping patients access care.
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33595253     DOI: 10.1097/AOG.0000000000004294

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

2.  Gynecological Providers' Willingness to Prescribe Gender-Affirming Hormone Therapy for Transgender Patients.

Authors:  Deirdre A Shires; Lucas R Prieto; Michael R Woodford; Kim D Jaffee; Daphna Stroumsa
Journal:  Transgend Health       Date:  2022-08-01

3.  Digital Scarlet Letters: Sexually Transmitted Infections in the Electronic Medical Record.

Authors:  Sarah Bennett; Denis R Newman-Griffis; Mary Catherine Beach; Marielle Gross
Journal:  Sex Transm Dis       Date:  2021-11-12       Impact factor: 3.868

Review 4.  The Effect of Gender-Affirming Medical Care on the Vaginal and Neovaginal Microbiomes of Transgender and Gender-Diverse People.

Authors:  Yonah Krakowsky; Emery Potter; Jason Hallarn; Bern Monari; Hannah Wilcox; Greta Bauer; Jacques Ravel; Jessica L Prodger
Journal:  Front Cell Infect Microbiol       Date:  2022-01-21       Impact factor: 5.293

Review 5.  Human Papillomavirus Infection: Knowledge, Risk Perceptions and Behaviors among SMW and AFAB.

Authors:  Magdalena Piróg; Bartosz Grabski; Robert Jach; Andrzej Zmaczyński; Magdalena Dutsch-Wicherek; Andrzej Wróbel; Klaudia Stangel-Wójcikiewicz
Journal:  Diagnostics (Basel)       Date:  2022-03-29

6.  Cystic Teratoma Resection With Ovarian Preservation in a Pediatric Transgender Male: A Case Report.

Authors:  Angelo Federico; Mehana Patel; Kristina Cummings
Journal:  Cureus       Date:  2022-09-14

7.  LGBTQ+ individuals and pregnancy outcomes: A commentary.

Authors:  Julie Croll; Laura Sanapo; Ghada Bourjeily
Journal:  BJOG       Date:  2022-03-25       Impact factor: 7.331

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.